FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Torsten Nielsen

Research Profile

Chemicals & Drugs

Disorders

Procedures

Devices

Oligonucleotide Array Sequence Analysis

Physiology

Gene Expression Regulation, Neoplastic

Concepts & Ideas

Co-author Network

Publications

TOP 3
Anna Isphording; Nataliya Nelnyk; Torsten O Nielsen; Marisa R Nucci; Rola H Ali; C Blake Gilks; Angela Goytain; Lien N Hoang; David G Huntsman; Julie Irving; Cheng-Han Lee
YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
Aleix Prat; Scott Tyldesley; Philip S Bernard; Rosalía Caballero; Eva Carrasco; Maggie Chon U Cheang; Karen Gelmon; Miguel Martín; Torsten O Nielsen; Joel S Parker; Charles M Perou
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Aleix Prat; J Bergh; Philip S Bernard; L A Carey; M C U Cheang; Stephen K Chia; M J Ellis; C Fan; L D Miller; Torsten O Nielsen; J S Parker; Charles M Perou
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Torsten Nielsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna Isphording; Nataliya Nelnyk; Torsten O Nielsen; Marisa R Nucci; Rola H Ali; C Blake Gilks; Angela Goytain; Lien N Hoang; David G Huntsman; Julie Irving; Cheng-Han Lee
YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
Human pathology 2013;44(5):837-43.
2013: Aleix Prat; Scott Tyldesley; Philip S Bernard; Rosalía Caballero; Eva Carrasco; Maggie Chon U Cheang; Karen Gelmon; Miguel Martín; Torsten O Nielsen; Joel S Parker; Charles M Perou
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):203-9.
2012: Aleix Prat; J Bergh; Philip S Bernard; L A Carey; M C U Cheang; Stephen K Chia; M J Ellis; C Fan; L D Miller; Torsten O Nielsen; J S Parker; Charles M Perou
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(11):2866-73.
2012: Cheng-Han Lee; Samuel Leung; Adrian Marino-Enriquez; Nataliya Nelnyk; Torsten O Nielsen; Esther Oliva; Marjan Rouzbahman; Matt van de Rijn; Meijun Zhu; Rola H Ali; C Blake Gilks; Alayne L Brunner; Sarah Chiang; Paola Dal Cin; Jonathan A Fletcher; Xiangqian Guo; David G Huntsman; Marisa R Nucci
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
The American journal of surgical pathology 2012;36(10):1562-70.
2012: Jason R Karamchandani; Torsten O Nielsen; Matt van de Rijn; Robert B West
Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2012;20(5):445-50.
2012: Makoto Endo; Torsten O Nielsen
Pazopanib for metastatic soft-tissue sarcoma.
Lancet 2012;380(9844):801; author reply 801.
2012: Jennifer R Won; James Cupples; Dongxia Gao; Dennis Grant; Torsten O Nielsen; Amir Rahemtulla; Robert Wolber; Cyril B Gilks
Variable performance of commercial epidermal growth factor receptor antibodies in detection of basal-like breast cancer.
Histopathology 2012;61(3):518-9.
2012: Stephen K Chia; Matthew J Ellis; Shan Jiang; Samuel Leung; Elaine Mardis; Joel S Parker; Charles M Perou; Kathleen I Pritchard; Lois E Shepherd; Dongsheng Tu; Karen Ung; Tammi Vickery; Philip S Bernard; Vivien H Bramwell; Torsten O Nielsen
A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(16):4465-72.
2012: Maggie C U Cheang; Stephen K Chia; Sherri Davies; Carole Davis; Mark T W Ebbert; Matthew J Ellis; Shan Jiang; Samuel Leung; Mark N Levine; Joel S Parker; Charles M Perou; Kathleen I Pritchard; Lois E Shepherd; Inge J Stijleman; Dongsheng Tu; K David Voduc; Philip S Bernard; Torsten O Nielsen
Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(8):2402-12.
2012: Le Su; Tully Underhill; Lin Yi; Mario R Capecchi; Angela Goytain; Kevin B Jones; Juergen Kast; Shujun Lin; Marina Pacheco; Neal Poulin; Fabio M Rossi; Arthur V Sampaio; Torsten O Nielsen
Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.
Cancer cell 2012;21(3):333-47.
2012: Pernille Braemer Hertel; Maj-Britt Jensen; Shan Jiang; Eva Balslev; Annette Bartels; Nils Brünner; Bent Ejlertsen; Frances P O'Malley; Kathleen I Pritchard; Lois E Shepherd; Dongsheng Tu; Torsten O Nielsen
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients.
Breast cancer research and treatment 2012;132(1):225-34.
2012: Marina Pacheco; Torsten O Nielsen
Histone deacetylase 1 and 2 in mesenchymal tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(2):222-30.
2012: Shuzhen Liu; William D Foulkes; Dongxia Gao; Jonathan Lachapelle; Samuel Leung; Torsten O Nielsen
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.
Breast cancer research : BCR 2012;14(2):R48.
2011: Mitch Dowsett; Matthew Ellis; Daniel F Hayes; N Lynn Henry; Judith C Hugh; Tracy Lively; Lisa McShane; Torsten O Nielsen; Soon Paik; Frederique Penault-Llorca; Ljudmila Prudkin; Meredith Regan; Janine Salter; Ian E Smith; Christos Sotiriou; Giuseppe Viale; Jo Anne Zujewski; Roger A'Hern; John Bartlett; R Charles Coombes; Jack Cuzick
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Journal of the National Cancer Institute 2011;103(22):1656-64.
2011: Andrew H Beck; Samuel Leung; Robert J Marinelli; Torsten O Nielsen; Ankur R Sangoi; Matt van de Rijn; Marc J van de Vijver; Robert B West; Daphne Koller
Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.
Science translational medicine 2011;3(108):108ra113.
2011: Anna F Lee; Torsten O Nielsen; Adam Smith; Stephen Yip; Malcolm M Hayes; John X O'Connell
Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literature.
Human pathology 2011;42(11):1804-9.
2011: David L Rimm; Torsten O Nielsen; Scott D Jewell; Daniel C Rohrer; Gloria Broadwater; Frederic Waldman; Kisha A Mitchell; Baljit Singh; Gregory J Tsongalis; Wendy L Frankel; anthony magliocco; Jonathan F Lara; Eric D Hsi; Ira J Bleiweiss; Sunil S Badve; Beiyun Chen; Peter M Ravdin; Richard L Schilsky; Ann D Thor; Donald A Berry
Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2282-90.
2011: Andrew McPherson; Fereydoun Hormozdiari; Abdalnasser Zayed; Ryan Giuliany; Gavin Ha; Mark G F Sun; Malachi Griffith; Alireza Heravi Moussavi; Janine Senz; Nataliya Melnyk; Marina Pacheco; Marco A Marra; Martin Hirst; Torsten O Nielsen; S Cenk Sahinalp; David Huntsman; Sohrab P Shah
deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.
PLoS computational biology 2011;7(5):e1001138.
2011: Hassan Huwait; Adam Meneghetti; Torsten O Nielsen
Kaposi sarcoma of the adrenal gland resembling epithelioid angiosarcoma: a case report.
Sarcoma 2011;2011():898257.
2010: Torsten O Nielsen; Joel Parker; Samuel Leung; David Voduc; Mark Ebbert; Tammi Vickery; Sherri R Davies; Jacqueline Snider; Inge J Stijleman; Jerry Reed; Mary Cheang; Elaine R Mardis; Charles M Perou; Philip S Bernard; Matthew J Ellis
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(21):5222-32.
2010: L Su; H Cheng; A V Sampaio; Torsten O Nielsen; Tully Underhill
EGR1 reactivation by histone deacetylase inhibitors promotes synovial sarcoma cell death through the PTEN tumor suppressor.
Oncogene 2010;29(30):4352-61.
2010: Hagen Kennecke; Rinat Yerushalmi; Ryan Woods; Maggie Chon U Cheang; David Voduc; Caroline H Speers; Torsten O Nielsen; Karen Gelmon
Metastatic behavior of breast cancer subtypes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3271-7.
2010: K David Voduc; Maggie C U Cheang; Scott Tyldesley; Karen Gelmon; Torsten O Nielsen; Hagen Kennecke
Breast cancer subtypes and the risk of local and regional relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1684-91.
2010: Torsten O Nielsen; Robert B West
Translating gene expression into clinical care: sarcomas as a paradigm.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1796-805.
2010: Torsten O Nielsen
Discovery research to clinical trial: a ten year journey.
Clinical and investigative medicine. Médecine clinique et experimentale 2010;33(6):E342-8.
2010: Hongwei Cheng; Paul W Clarkson; Dongxia Gao; Marina Pacheco; Yuzhuo Wang; Torsten O Nielsen
Therapeutic Antibodies Targeting CSF1 Impede Macrophage Recruitment in a Xenograft Model of Tenosynovial Giant Cell Tumor.
Sarcoma 2010;2010():174528.
2010: Marina Pacheco; Douglas E Horsman; Malcolm M M Hayes; Paul W Clarkson; Hassan Huwait; Torsten O Nielsen
Small blue round cell tumor of the interosseous membrane bearing a t(2;22)(q34;q12)/EWS-CREB1 translocation: a case report.
Molecular cytogenetics 2010;3():12.
2010: Subbaya Subramanian; Venugopal Thayanithy; Robert B West; Cheng-Han Lee; Andrew H Beck; Shirley Zhu; Erinn Downs-Kelly; Kelli Montgomery; John R Goldblum; Pancras C W Hogendoorn; Christopher L Corless; Andre M Oliveira; Sarah M Dry; Torsten O Nielsen; Brian P Rubin; Jonathan A Fletcher; CD Fletcher; Matt van de Rijn
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.
The Journal of pathology 2010;220(1):58-70.
2010: Shuzhen Liu; Stephen K Chia; Erika Mehl; Samuel Leung; Ashish Rajput; Mary Cheang; Torsten O Nielsen
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Breast cancer research and treatment 2010;119(1):53-61.
2009: Amanda Jagdis; Brian P Rubin; Raymond R Tubbs; Marina Pacheco; Torsten O Nielsen
Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
The American journal of surgical pathology 2009;33(12):1743-51.
2009: Kristin C Jensen; Torsten O Nielsen; C Blake Gilks; Robert B West
HER2 Intermediate Breast Cancers.
The American journal of surgical pathology 2009;33(11):1739; author reply 1739-40.
2009: Hongwei Cheng; Jim Dodge; Erika Mehl; Shuzhen Liu; Neal Poulin; Matt van de Rijn; Torsten O Nielsen
Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
Human pathology 2009;40(9):1244-51.
2009: Sonja E Steigen; David F Schaeffer; Robert B West; Torsten O Nielsen
Expression of insulin-like growth factor 2 in mesenchymal neoplasms.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(7):914-21.
2009: Inigo Espinosa; Andrew H Beck; Cheng-Han Lee; Shirley Zhu; Kelli D Montgomery; Robert J Marinelli; Kristen N Ganjoo; Torsten O Nielsen; C Blake Gilks; Robert B West; Matt van de Rijn
Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.
The American journal of pathology 2009;174(6):2347-56.
2009: Maggie C U Cheang; Stephen K Chia; David Voduc; Dongxia Gao; Samuel Leung; Jacqueline Snider; Mark Watson; Sherri Davies; Philip S Bernard; Joel Parker; Charles M Perou; Matthew J Ellis; Torsten O Nielsen
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Journal of the National Cancer Institute 2009;101(10):736-50.
2009: Anna Adamiak; Cheng-Han Lee; Torsten O Nielsen; Douglas Webber; John X O'Connell
Duodenal epithelioid gastrointestinal stromal tumor with prominent granular cell features.
Human pathology 2009;40(4):599-602.
2009: Judith C Hugh; John Hanson; Maggie Chon U Cheang; Torsten O Nielsen; Charles M Perou; Charles Dumontet; John Reed; Maryla Krajewska; Isabelle Treilleux; Matthieu Rupin; Emmanuelle Magherini; John Mackey; Miguel Martin; Charles L Vogel
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1168-76.
2009: Joel Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1160-7.
2009: Anne Nguyen; Le Su; Belinda Campbell; Neal M Poulin; Torsten O Nielsen
Synergism of heat shock protein 90 and histone deacetylase inhibitors in synovial sarcoma.
Sarcoma 2009;2009():794901.
2008: Stephen Chia; Brian Norris; Caroline H Speers; Mary Cheang; Blake Gilks; Allen M Gown; David Huntsman; Ivo A Olivotto; Torsten O Nielsen; Karen Gelmon
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5697-704.
2008: David Voduc; Torsten O Nielsen
Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.
Clinical breast cancer 2008;8 Suppl 4():S171-8.
2008: Alan I So; Randy Levitt; Bernhard Eigl; Ladan Fazli; Motosugu Muramaki; Sam Leung; Maggie C U Cheang; Torsten O Nielsen; Martin Gleave; Michael Pollak
Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):6944-54.
2008: David Voduc; Torsten O Nielsen; Maggie C Cheang; William D Foulkes
The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Human pathology 2008;39(10):1431-7.
2008: Dmitry A Turbin; Samuel Leung; Mary Cheang; Hagen A Kennecke; Kelli D Montgomery; Steven McKinney; Diana O Treaba; Niki Boyd; Lynn C Goldstein; Sunil Badve; Allen M Gown; Matt van de Rijn; Torsten O Nielsen; C Blake Gilks; David Huntsman
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Breast cancer research and treatment 2008;110(3):417-26.
2008: Simon J Crabb; Mary Cheang; Samuel Leung; Taina Immonen; Torsten O Nielsen; David D Huntsman; Chris D Bajdik; Stephen K Chia
Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.
Clinical breast cancer 2008;8(3):249-56.
2008: Shuzhen Liu; Hongwei Cheng; Wanda Kwan; Joanna M Lubieniecka; Torsten O Nielsen
Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.
Molecular cancer therapeutics 2008;7(6):1751-61.
2008: Joanna M Lubieniecka; Diederik R H de Bruijn; Le Su; Anke H A van Dijk; Subbaya Subramanian; Matt van de Rijn; Neal Poulin; Ad Geurts van Kessel; Torsten O Nielsen
Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
Cancer research 2008;68(11):4303-10.
2008: Cheng-Han Lee; Inigo Espinosa; Kristin C Jensen; Subbaya Subramanian; Shirley X Zhu; Sushama Varma; Kelli D Montgomery; Torsten O Nielsen; Matt van de Rijn; Robert B West
Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(5):531-9.
2008: David Voduc; Challayne Kenney; Torsten O Nielsen
Tissue microarrays in clinical oncology.
Seminars in radiation oncology 2008;18(2):89-97.
2008: Cheng-Han Lee; Inigo Espinosa; Suzan Vrijaldenhoven; Subbaya Subramanian; Kelli D Montgomery; Shirley Zhu; Robert J Marinelli; Johannes L Peterse; Neal Poulin; Torsten O Nielsen; Robert B West; C Blake Gilks; Matt van de Rijn
Prognostic significance of macrophage infiltration in leiomyosarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1423-30.
2008: Mary Cheang; David Voduc; Chris D Bajdik; Samuel Leung; Steven McKinney; Stephen K Chia; Charles M Perou; Torsten O Nielsen
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1368-76.
2008: Inigo Espinosa; Cheng-Han Lee; Mi Kyung Kim; Bich-Tien Rouse; Subbaya Subramanian; Kelli Montgomery; Sushama Varma; Christopher L Corless; Michael C Heinrich; Kevin S Smith; Zhong Wang; Brian Rubin; Torsten O Nielsen; Robert S Seitz; Douglas T Ross; Robert B West; Michael L Cleary; Matt van de Rijn
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
The American journal of surgical pathology 2008;32(2):210-8.
2008: Sonja E Steigen; Bjørn Straume; Dmitry Turbin; Andy K W Chan; Samuel Leung; Torsten O Nielsen; Sigurd Lindal
Clinicopathologic factors and nuclear morphometry as independent prognosticators in KIT-positive gastrointestinal stromal tumors.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2008;56(2):139-45.
2008: Golareh Habibi; Samuel Leung; Jennifer H Law; Karen Gelmon; Hamid Masoudi; Dmitry Turbin; Michael Pollak; Torsten O Nielsen; David Huntsman; Sandra E Dunn
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
Breast cancer research : BCR 2008;10(5):R86.
2008: Mary Cheang; Matt van de Rijn; Torsten O Nielsen
Gene expression profiling of breast cancer.
Annual review of pathology 2008;3():67-97.
2008: Sonja E Steigen; Bodil Bjerkehagen; Hans K Haugland; Ivar Nordrum; Else Marit Løberg; Vidar Isaksen; Tor J Eide; Torsten O Nielsen
Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(1):46-53.
2008: E J Heffernan; F O Alkubaidan; Torsten O Nielsen; Peter Munk
The imaging appearances of metallosis.
Skeletal radiology 2008;37(1):59-62.
2007: Tony L Ng; Maureen J O'Sullivan; Catherine J Pallen; Malcolm Hayes; Paul W Clarkson; Mark Winstanley; Poul H B Sorensen; Torsten O Nielsen; Douglas E Horsman
Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV.
The Journal of molecular diagnostics : JMD 2007;9(4):459-63.
2007: Jay S Wunder; Torsten O Nielsen; ROBERT G MAKI; Brian O'sullivan; Benjamin A Alman
CYP3A4/5 and pharmacogenetics in patients with sarcoma - Authors' reply.
The lancet oncology 2007;8(8):668-9.
2007: Sunil Badve; Dmitry Turbin; Mangesh Thorat; Akira Morimiya; Torsten O Nielsen; Charles M Perou; Sandi Dunn; David Huntsman; Harikrishna Nakshatri
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4415-21.
2007: Jay S Wunder; Torsten O Nielsen; ROBERT G MAKI; Brian O'Sullivan; Benjamin A Alman
Opportunities for improving the therapeutic ratio for patients with sarcoma.
The lancet oncology 2007;8(6):513-24.
2007: John S Cupp; Melinda A Miller; Kelli D Montgomery; Torsten O Nielsen; John X O'Connell; David Huntsman; Matt van de Rijn; C Blake Gilks; Robert B West
Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
The American journal of surgical pathology 2007;31(6):970-6.
2007: Jefferson Terry; Tsuyoshi Saito; Subbaya Subramanian; Cindy Ruttan; Cristina R Antonescu; John R Goldblum; Erinn Downs-Kelly; Christopher L Corless; Brian P Rubin; Matt van de Rijn; Marc Ladanyi; Torsten O Nielsen
TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.
The American journal of surgical pathology 2007;31(2):240-6.
2007: Emad A Rakha; David S P Tan; William D Foulkes; Ian O Ellis; Andrew Tutt; Torsten O Nielsen; Jorge S Reis-Filho
Are triple-negative tumours and basal-like breast cancer synonymous?
Breast cancer research : BCR 2007;9(6):404; author reply 405.
2007: Anna L Stratford; Golareh Habibi; Arezoo Astanehe; Helen Jiang; Kaiji Hu; Eugene Park; Ashleen Shadeo; Timon P H Buys; Wan Lam; Trevor Pugh; Marco Marra; Torsten O Nielsen; Uwe Klinge; Peter R Mertens; Samuel Aparicio; Sandra E Dunn
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
Breast cancer research : BCR 2007;9(5):R61.
2007: Marc Tischkowitz; Jean-Sebastien Brunet; Louis R Bégin; David G Huntsman; Mary Cheang; Lars A Akslen; Torsten O Nielsen; William D Foulkes
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.
BMC cancer 2007;7():134.
2006: Mary Cheang; Diana Treaba; Caroline H Speers; Ivo A Olivotto; Chris D Bajdik; Stephen K Chia; Lynn C Goldstein; Karen Gelmon; David Huntsman; C Blake Gilks; Torsten O Nielsen; Allen M Gown
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5637-44.
2006: Fruma Yehiely; Jose Moyano; Joseph R Evans; Torsten O Nielsen; Vincent L Cryns
Deconstructing the molecular portrait of basal-like breast cancer.
Trends in molecular medicine 2006;12(11):537-44.
2006: Nizar A Al-Nakshabandi; Torsten O Nielsen; Peter Munk
Radiology for the surgeon. Musculoskeletal case 37.
Canadian journal of surgery. Journal canadien de chirurgie 2006;49(4):283-4.
2006: Torsten O Nielsen
Microarray analysis of sarcomas.
Advances in anatomic pathology 2006;13(4):166-73.
2006: Brian Z Ring; Robert S Seitz; Rod Beck; William J Shasteen; Shannon Tarr; Mary Cheang; Brian J Yoder; G Thomas Budd; Torsten O Nielsen; David G Hicks; Noel C Estopinal; Douglas T Ross
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3039-47.
2006: Lisa A Carey; Charles M Perou; Chad A Livasy; Lynn Dressler; David Cowan; Kathleen Dorsey; Gamze Karaca; Melissa A Troester; Chiu-Kit Tse; Sharon N Edmiston; Sandra L Deming; Joseph Geradts; Mary Cheang; Torsten O Nielsen; Patricia G Moorman; Henry Earp; Robert C Millikan
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
JAMA : the journal of the American Medical Association 2006;295(21):2492-502.
2006: Grace Callagy; Paul D P Pharoah; Sarah Elizabeth Pinder; Forrest D Hsu; Torsten O Nielsen; Joseph Ragaz; Ian O Ellis; David Huntsman; Carlos Caldas
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2468-75.
2006: Robert B West; Brian P Rubin; Melinda A Miller; Subbaya Subramanian; Gulsah Kaygusuz; Kelli Montgomery; Shirley Zhu; Robert J Marinelli; Alessandro De Luca; Erinn Downs-Kelly; John R Goldblum; Christopher L Corless; Patrick O Brown; C Blake Gilks; Torsten O Nielsen; David Huntsman; Matt van de Rijn
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(3):690-5.
2006: Jose Moyano; Joseph R Evans; Feng Chen; Meiling Lu; Michael E Werner; Fruma Yehiely; Leslie K Diaz; Dmitry Turbin; Gamze Karaca; Elizabeth Louise Wiley; Torsten O Nielsen; Charles M Perou; Vincent L Cryns
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.
The Journal of clinical investigation 2006;116(1):261-70.
2006: Dmitry Turbin; Mary Cheang; Chris D Bajdik; Karen Gelmon; Erika Yorida; Alessandro De Luca; Torsten O Nielsen; David Huntsman; C Blake Gilks
MDM2 protein expression is a negative prognostic marker in breast carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(1):69-74.
2005: Joanna M Lubieniecka; Torsten O Nielsen
cDNA microarray-based translational research in soft tissue sarcoma.
Journal of surgical oncology 2005;92(4):267-71.
2005: Chih Long Liu; Kelli D Montgomery; Yasodha Natkunam; Robert B West; Torsten O Nielsen; Mary Cheang; Dmitry Turbin; Robert J Marinelli; Matt van de Rijn; John P Higgins
TMA-Combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(12):1641-8.
2005: Leah M Prentice; Ashleen Shadeo; Valia Lestou; Melinda A Miller; Ronald deLeeuw; Nikita Makretsov; Dmitry Turbin; Lindsay A Brown; Nicol Macpherson; Erika Yorida; Mary Cheang; John Bentley; Stephen Chia; Torsten O Nielsen; C Blake Gilks; Wan Lam; David Huntsman
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
Oncogene 2005;24(49):7281-9.
2005: Jefferson Terry; Joanna M Lubieniecka; Wanda Kwan; Suzanne Liu; Torsten O Nielsen
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5631-8.
2005: Subbaya Subramanian; Robert B West; Robert J Marinelli; Torsten O Nielsen; Brian P Rubin; John R Goldblum; Rajiv M Patel; Shirley Zhu; Kelli Montgomery; Tony L Ng; Christopher L Corless; Michael C Heinrich; Matt van de Rijn
The gene expression profile of extraskeletal myxoid chondrosarcoma.
The Journal of pathology 2005;206(4):433-44.
2005: Jefferson Terry; Todd S Barry; Douglas E Horsman; Forrest D Hsu; Allen M Gown; David Huntsman; Torsten O Nielsen
Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2005;14(2):77-82.
2005: Robert B West; Dimitry S A Nuyten; Subbaya Subramanian; Torsten O Nielsen; Christopher L Corless; Brian P Rubin; Kelli Montgomery; Shirley Zhu; Rajiv M Patel; Tina Hernandez-Boussard; John R Goldblum; Patrick O Brown; Marc J van de Vijver; Matt van de Rijn
Determination of stromal signatures in breast carcinoma.
PLoS biology 2005;3(6):e187.
2005: Sam M Wiseman; Nikita Makretsov; Torsten O Nielsen; Blake Gilks; Erika Yorida; Mary Cheang; Dmitry Turbin; Karen Gelmon; David Huntsman
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.
Cancer 2005;103(9):1770-7.
2005: Tony L Ng; Allen M Gown; Todd S Barry; Mary Cheang; Andy K W Chan; Dmitry Turbin; Forrest D Hsu; Robert B West; Torsten O Nielsen
Nuclear beta-catenin in mesenchymal tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(1):68-74.
2004: Subbaya Subramanian; Robert B West; Christopher L Corless; Wenbin Ou; Brian P Rubin; Kent-Man Chu; Suet Yi Leung; Siu Tsan Yuen; Shirley Zhu; Tina Hernandez-Boussard; Kelli Montgomery; Torsten O Nielsen; Rajiv M Patel; John R Goldblum; Michael C Heinrich; Jonathan A Fletcher; Matt van de Rijn
Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles.
Oncogene 2004;23(47):7780-90.
2004: Nikita Makretsov; David Huntsman; Torsten O Nielsen; Erika Yorida; Michael Peacock; Mary Cheang; Sandra E Dunn; Malcolm Hayes; Matt van de Rijn; Chris D Bajdik; C Blake Gilks
Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):6143-51.
2004: Torsten O Nielsen; Forrest D Hsu; Kristin Jensen; Mary Cheang; Gamze Karaca; Zhiyuan Hu; Tina Hernandez-Boussard; Chad A Livasy; Dave Cowan; Lynn Dressler; Lars A Akslen; Joseph Ragaz; Allen M Gown; C Blake Gilks; Matt van de Rijn; Charles M Perou
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5367-74.
2004: Robert B West; Jeff D Harvell; Sabine C Linn; Chih Long Liu; Wijan Prapong; Tina Hernandez-Boussard; Kelli Montgomery; Torsten O Nielsen; Brian P Rubin; Rajiv M Patel; John R Goldblum; Patrick O Brown; Matt van de Rijn; Chih Long Lui
Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans.
The American journal of surgical pathology 2004;28(8):1063-9.
2004: Robert B West; Christopher L Corless; Xin Chen; Brian P Rubin; Subbaya Subramanian; Kelli Montgomery; Shirley Zhu; Catherine A Ball; Torsten O Nielsen; Rajiv M Patel; John R Goldblum; Patrick O Brown; Michael C Heinrich; Matt van de Rijn
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
The American journal of pathology 2004;165(1):107-13.
2004: Torsten O Nielsen; Heather N Andrews; Mary Cheang; Jill E Kucab; Forrest D Hsu; Joseph Ragaz; C Blake Gilks; Nikita Makretsov; Chris D Bajdik; Christy Brookes; Leonard M Neckers; Valentina Evdokimova; David Huntsman; Sandra E Dunn
Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.
Cancer research 2004;64(1):286-91.
2003: Sabine C Linn; Robert B West; Jonathan R Pollack; Shirley Zhu; Tina Hernandez-Boussard; Torsten O Nielsen; Brian P Rubin; Rajiv M Patel; John R Goldblum; David Siegmund; David Botstein; Patrick O Brown; C Blake Gilks; Matt van de Rijn
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.
The American journal of pathology 2003;163(6):2383-95.
2003: Torsten O Nielsen; Forrest D Hsu; John X O'Connell; C Blake Gilks; Poul H B Sorensen; Sabine Linn; Robert B West; Chih Long Liu; David Botstein; Patrick O Brown; Matt van de Rijn
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
The American journal of pathology 2003;163(4):1449-56.
2002: Forrest D Hsu; Torsten O Nielsen; Abdulmohsen Alkushi; Beverley Dupuis; David Huntsman; Chih Long Liu; Matt van de Rijn; C Blake Gilks
Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(12):1374-80.
2002: Torsten O Nielsen; Robert B West; Sabine C Linn; Orly Alter; Margaret A Knowling; John X O'Connell; Shirley Zhu; Michael Fero; Gavin Sherlock; Jonathan R Pollack; Patrick O Brown; David Botstein; Matt van de Rijn
Molecular characterisation of soft tissue tumours: a gene expression study.
Lancet 2002;359(9314):1301-7.
2002: Tatjana Crnogorac-Jurcevic; Torsten O Nielsen; Nick Lemoine
RT-PCR from laser-capture microdissected samples.
Methods in molecular biology (Clifton, N.J.) 2002;193():197-204.
2000: Torsten O Nielsen; G Séjean; R M Onerheim
Paraganglioma of the tongue.
Archives of pathology & laboratory medicine 2000;124(6):877-9.
2000: Torsten O Nielsen; Nandini Cossons; Maria Zannis-Hadjopoulos; Gerald B Price
Circular YAC vectors containing short mammalian origin sequences are maintained under selection as HeLa episomes.
Journal of cellular biochemistry 2000;76(4):674-85.
1997: Nandini Cossons; Torsten O Nielsen; C Dini; N Tomilin; D B Young; Karl Riabowol; J B Rattner; Randal Johnston; Maria Zannis-Hadjopoulos; Gerald B Price
Circular YAC vectors containing a small mammalian origin sequence can associate with the nuclear matrix.
Journal of cellular biochemistry 1997;67(4):439-50.